Dr. Reddy's Laboratories Ltd. (RDY)
12.22
-0.12
(-1.01%)
USD |
NYSE |
Aug 26, 15:32
Dr. Reddy's Laboratories Shareholders Equity (Quarterly) : 4.051B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.051B |
| March 31, 2026 | 3.975B |
| December 31, 2025 | 4.143B |
| September 30, 2025 | 4.038B |
| June 30, 2025 | 4.082B |
| March 31, 2025 | 3.901B |
| December 31, 2024 | 3.711B |
| September 30, 2024 | 3.644B |
| June 30, 2024 | 3.533B |
| March 31, 2024 | 3.364B |
| December 31, 2023 | 3.219B |
| September 30, 2023 | 3.048B |
| June 30, 2023 | 2.990B |
| March 31, 2023 | 2.811B |
| December 31, 2022 | 2.663B |
| September 30, 2022 | 2.535B |
| June 30, 2022 | 2.537B |
| March 31, 2022 | 2.514B |
| December 31, 2021 | 2.556B |
| September 30, 2021 | 2.478B |
| June 30, 2021 | 2.396B |
| March 31, 2021 | 2.367B |
| December 31, 2020 | 2.318B |
| September 30, 2020 | 2.241B |
| June 30, 2020 | 2.142B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.049B |
| December 31, 2019 | 2.083B |
| September 30, 2019 | 2.170B |
| June 30, 2019 | 2.118B |
| March 31, 2019 | 2.024B |
| December 31, 2018 | 1.944B |
| September 30, 2018 | 1.813B |
| June 30, 2018 | 1.904B |
| March 31, 2018 | 1.939B |
| December 31, 2017 | 1.938B |
| September 30, 2017 | 1.865B |
| June 30, 2017 | 1.909B |
| March 31, 2017 | 1.910B |
| December 31, 2016 | 1.783B |
| September 30, 2016 | 1.731B |
| June 30, 2016 | 1.691B |
| March 31, 2016 | 1.938B |
| December 31, 2015 | |
| September 30, 2015 | 1.850B |
| June 30, 2015 | |
| March 31, 2015 | 1.779B |
| December 31, 2014 | |
| September 30, 2014 | 1.603B |
| June 30, 2014 | |
| March 31, 2014 | 1.520B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 46.50B |
| Teva Pharmaceutical Industries Ltd. | 7.753B |
| Novo Nordisk A/S | 33.84B |
| Perrigo Co. Plc | 2.516B |
| Innoviva, Inc. | 1.233B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.078B |
| Total Liabilities (Quarterly) | 1.992B |
| Debt to Equity Ratio | 0.1877 |
| Current Ratio | 1.902 |
| Net Debt Paydown Yield | -0.35% |